Your browser doesn't support javascript.
loading
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase ß: data from the Fabry Registry.
Ortiz, Alberto; Abiose, Ademola; Bichet, Daniel G; Cabrera, Gustavo; Charrow, Joel; Germain, Dominique P; Hopkin, Robert J; Jovanovic, Ana; Linhart, Ales; Maruti, Sonia S; Mauer, Michael; Oliveira, João P; Patel, Manesh R; Politei, Juan; Waldek, Stephen; Wanner, Christoph; Yoo, Han-Wook; Warnock, David G.
Afiliación
  • Ortiz A; Unidad de Dialisis, IIS-Fundacion Jimenez Diaz/UAM, IRSIN, Madrid, Spain.
  • Abiose A; North Ohio Heart Center, Westlake, Ohio, USA.
  • Bichet DG; Hôpital du Sacré-Coeur de Montréal and University of Montreal, Montreal, QC, Canada.
  • Cabrera G; Grupo Medico Del Viso, Buenos Aires, Argentina.
  • Charrow J; Division of Genetics, Birth Defects, and Metabolism, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Germain DP; Division of Medical Genetics, University of Versailles-St Quentin en Yvelines, Versailles, France Assistance Publique-Hôpitaux de Paris, Garches, France.
  • Hopkin RJ; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Jovanovic A; Department of Endocrinology and Metabolic Medicine, Salford Royal NHS Foundation Trust, Salford, UK.
  • Linhart A; Department of Internal Medicine, School of Medicine, Charles University, Prague, Czech Republic.
  • Maruti SS; Genzyme, a Sanofi Company, Cambridge, Massachusetts, USA.
  • Mauer M; Departments of Pediatrics and Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Oliveira JP; Department of Genetics, São João Hospital Centre & Faculty of Medicine, University of Porto, Porto, Portugal I3S-Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Patel MR; Division of Cardiovascular Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
  • Politei J; Department of Neurology, Fundacion Para el Estudio de Enfermedades Neurometabolicas (FESEN), Buenos Aires, Argentina.
  • Waldek S; University of Sunderland, Sunderland, UK.
  • Wanner C; Division of Nephrology, University Clinic, University of Würzburg, Würzburg, Germany.
  • Yoo HW; Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Warnock DG; Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
J Med Genet ; 53(7): 495-502, 2016 07.
Article en En | MEDLINE | ID: mdl-26993266
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa / Isoenzimas Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Genet Año: 2016 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa / Isoenzimas Tipo de estudio: Incidence_studies / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Genet Año: 2016 Tipo del documento: Article País de afiliación: España